	Catalent’s new OptiForm Solution Suite combines both predictive and high throughput screening platforms - designed to identify the most stable and efficient drug form of an API - with delivery technology feasibility studies, and expert input from multi-disciplinary teams to address key developmental challenges.
	 

	OptiForm Solution Suite is designed to efficiently and rapidly help solve complex bioavailability challenges for early stage molecules by integrating superior expertise and know-how to match the best, most innovative, drug delivery technologies to each developmental molecule, with the goal of providing optimal animal PK materials in just twelve weeks.

	OptiForm Solution Suite helps enable faster development with a 3-step process:

		ASSESS: By applying proven high throughput screening tools, detailed pre-formulation data are collected to characterise the molecule's potential challenges.
		 

		ENHANCE: Formulation development and technology experts determine the feasibility of the proposed formulation approaches, recommend candidate formulations and collect preliminary stability data.
		 

		DELIVER: In twelve weeks, a dedicated advisor will provide a recommended path forward, based on rigorous data, accompanied by animal PK study materials to enter animal trials with optimised product faster.
		 

Catalent’s Optiform® Solution Suite platform integrates four technologies to match the best drug delivery methodologies to developmental API molecules, with the goal of providing optimal animal PK prototypes in just twelve weeks.